PAMAM dendrimers with an ethylenediamine core (e.g., Generation 3.0) serve as bifunctional chelating agents capable of binding radionuclides to form radiopharmaceutical conjugates (RDCs); these RDCs exhibit specific targeting capabilities toward biomolecules and can be applied in medical imaging or therapy.